AU4451601A - Genetically engineered clone of hepatitis e virus (hev) genome which is infectious, its production and uses - Google Patents

Genetically engineered clone of hepatitis e virus (hev) genome which is infectious, its production and uses

Info

Publication number
AU4451601A
AU4451601A AU44516/01A AU4451601A AU4451601A AU 4451601 A AU4451601 A AU 4451601A AU 44516/01 A AU44516/01 A AU 44516/01A AU 4451601 A AU4451601 A AU 4451601A AU 4451601 A AU4451601 A AU 4451601A
Authority
AU
Australia
Prior art keywords
hev
hepatitis
infectious
genome
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44516/01A
Inventor
Shripa Agrawal
Israrul Haque Ansari
Hemlata Durgapal
Subrat Kumar Panda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
All India Institute of Medical Sciences AIIMS
Department of Science and Technology of Ministry of Science and Technology India
Original Assignee
All India Institute of Medical Sciences AIIMS
Department of Science and Technology of Ministry of Science and Technology India
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by All India Institute of Medical Sciences AIIMS, Department of Science and Technology of Ministry of Science and Technology India filed Critical All India Institute of Medical Sciences AIIMS
Publication of AU4451601A publication Critical patent/AU4451601A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/28011—Hepeviridae
    • C12N2770/28111—Hepevirus, e.g. hepatitis E virus
    • C12N2770/28121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/28011—Hepeviridae
    • C12N2770/28111—Hepevirus, e.g. hepatitis E virus
    • C12N2770/28161—Methods of inactivation or attenuation
    • C12N2770/28162—Methods of inactivation or attenuation by genetic engineering

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU44516/01A 2000-02-07 2001-02-05 Genetically engineered clone of hepatitis e virus (hev) genome which is infectious, its production and uses Abandoned AU4451601A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN106DE2000 2000-02-07
IN106/DEL/2000 2000-02-07
PCT/IN2001/000015 WO2001057073A2 (en) 2000-02-07 2001-02-05 Infectious cdna clone of hepatitis e virus (hev) genome, its production and uses

Publications (1)

Publication Number Publication Date
AU4451601A true AU4451601A (en) 2001-08-14

Family

ID=11097025

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44516/01A Abandoned AU4451601A (en) 2000-02-07 2001-02-05 Genetically engineered clone of hepatitis e virus (hev) genome which is infectious, its production and uses

Country Status (3)

Country Link
EP (1) EP1169341A1 (en)
AU (1) AU4451601A (en)
WO (1) WO2001057073A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002365931A1 (en) * 2001-11-09 2003-09-02 The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt Hepatitis e virus clones and methods of their use
MX2022001468A (en) 2019-08-09 2022-07-19 Nutcracker Therapeutics Inc Methods and apparatuses for manufacturing for removing material from a therapeutic composition.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010580A2 (en) * 1994-10-03 1996-04-11 The Government Of The United States Of America, Re Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines

Also Published As

Publication number Publication date
WO2001057073A2 (en) 2001-08-09
EP1169341A1 (en) 2002-01-09
WO2001057073A3 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AU2002230763A1 (en) Inhibitors of hepatitis c virus ns3 protease
AU2001245356A1 (en) Inhibitors of hepatitis c virus ns3 protease
AU2055301A (en) Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
AU2001280640A1 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
AU2001277967A1 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
AU2003284689A8 (en) Nucleic acid construct containing hepatitis c virus (hcv) of genocype 2a genome-origin nucleic acid and cell having the nucleic acid construct transferred thereinto
AU2002348151A1 (en) Viral vector production methods and compositions
AU2002346686A1 (en) Compositions and method for treating hepatitis virus infection
AU2003216523A1 (en) Treatment of pre-core hepatitis b virus mutant infections
AU2002225509A1 (en) Production and of viruses, viral isolates and vaccines
HUP0401585A3 (en) Infectious bovine viral diarrhea virus clone
AU2002225895A1 (en) Hepatitis c virus constructs characterized by high efficiency replication
AU2001291162A1 (en) Production of viral vectors
EP1141255A4 (en) Modified forms of hepatitis c virus ns3 protease
AU2001269092A1 (en) Inhibitors of hepatitis b virus infection
WO2001060838A3 (en) Aids ancestral viruses and vaccines
AU4451601A (en) Genetically engineered clone of hepatitis e virus (hev) genome which is infectious, its production and uses
WO2003053332A3 (en) Composition and method for treating viral infection
AU5460900A (en) Infectious cdna clone of gb virus b and uses thereof
AU2003301865A1 (en) Epitopes of hepatitis c virus
EP1521849A4 (en) Hepatitis a virus nucleotide sequences, recombinant proteins and uses thereof
AU2001282560A1 (en) Methods of infection with hepatitis c virus
EP1421222A4 (en) Cell culture system for synthesis of infectious hepatitis c virus
AU2001256675A1 (en) Method of preparing virus vector
AU2001257505A1 (en) Hepatitis c virus helicase crystals, crystallographic structure and methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase